Skip to content

Clinical trials

Phase 1 Eye Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Eye Diseases Phase: Phase 1 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20081
20091
20104
20111
20121
20131
20151
20161
20171
20181
20201
20213
20221
20234
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting3
Unknown status3
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Pfizer2
Active Biotech AB1
Adverum Biotechnologies, Inc.1
Amakem, NV1
David M. Brown, M.D.1
Eye & ENT Hospital of Fudan University1
Genzyme, a Sanofi Company1
InnoVec Biotherapeutics Inc.1
Kukje Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Eye Diseases27
Macular Degeneration8
Retinal Degeneration7
Retinal Diseases7
Glaucoma5
Ocular Hypertension3
Blindness2
Optic Nerve Injuries2
Retinitis Pigmentosa2
Amblyopia1

Trials

Showing 51 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.